Gene expression assays as prognostic and predictive markers in early stage non-small cell lung cancer.

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

Who cites it

14 citing papers in PubMed, 3 syntheses or guidelines pooled it.

1. Prognostic Significance of EZH2 Expression in Non-Small Cell Lung Cancer: A Meta-analysis.Scientific reports · 2016
   Pooled it
2. Prognostic value of the neutrophil to lymphocyte ratio in lung cancer: A meta-analysis.Clinics (Sao Paulo, Brazil) · 2015
   Pooled it
3. Prognostic significance of preoperative serum carcinoembryonic antigen in non-small cell lung cancer: a meta-analysis.Tumour biology : the journal of the International Society for Oncodevelopmental Biology and Medicine · 2014
   Pooled it
4. The Prognostic Significance of Pretreatment White Blood Cell and Platelet Counts for Survival Outcome in Primary Lung Cancer.Materia socio-medica · 2024
   Article
5. Development and validation of two prognostic nomograms for predicting survival in patients with non-small cell and small cell lung cancer.Oncotarget · 2017
   Article
6. The Prognostic Value of Pre-Treatment Leukocytosis in Patients with Previously Treated, Stage IIIB/IV Non-Small Cell Lung Cancer Treated with the IGF-1R Pathway Modulator AXL1717 or Docetaxel; a Retrospective Analysis of a Phase II TrialAsian Pacific journal of cancer prevention : APJCP · 2017
   Article
7. Prognostic significance of β-catenin expression in patients with non-small cell lung cancer: a meta-analysis.Translational lung cancer research · 2017
   Article
8. Prognostic value of wingless-type proteins in non-small cell lung cancer patients: a meta-analysis.Translational lung cancer research · 2016
   Article
9. Lymphocyte to monocyte ratio is associated with response to first-line platinum-based chemotherapy and prognosis of early-stage non-small cell lung cancer patients.Tumour biology : the journal of the International Society for Oncodevelopmental Biology and Medicine · 2016
   Article
10. PD-L1 over-expression and survival in patients with non-small cell lung cancer: a meta-analysis.Translational lung cancer research · 2015
    Article
11. Prognostic value of programmed cell death-ligand 1 expression in patients with non-small-cell lung cancer: evidence from an updated meta-analysis.OncoTargets and therapy · 2015
    Article
12. Pretreatment neutrophil to lymphocyte ratio is associated with response to therapy and prognosis of advanced non-small cell lung cancer patients treated with first-line platinum-based chemotherapy.Cancer immunology, immunotherapy : CII · 2013
    Article
13. Prognostic value of COX-2 expression in patients with non-small cell lung cancer: a systematic review and meta-analysis.Journal of thoracic disease · 2013
    Article
14. Prognostic Value of Thyroid Transcription Factor-1 Expression in Patients with Advanced Lung Adenocarcinoma.In vivo (Athens, Greece)
    Article

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

Authors and funding

5 authors.

Funding

No grant is acknowledged in the PubMed record.

Abstract

PubMed holds no abstract for this paper.